Latest news

[PRESS RELEASE] A partnership between Explicyte and Bergonié Institute fuels major breakthroughs

06 / 20 / 2023

[PRESS RELEASE] A partnership between Explicyte and Bergonié Institute fuels major breakthroughs

Over the past four years, Explicyte and Bergonié Institute have been conducting joint translational research programs to identify determinants of cancer patients' responsiveness to immunotherapy. Among these efforts, Explicyte and a research team led by Pr. Italiano at Bergonié Institute identified a key biomarker predictive of the efficacy of immunotherapy in oncology.

Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers

05 / 23 / 2023

Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers

Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers
Laboratory Investigation, 2023, May

L Vanhersecke, A Bougouin, A Crombé, M Brunet, C Sofeu, M Parrens, H Pierron, B Bonhomme, N Lembege, C Rey, V Velasco, I Soubeyran, H Begueret, A Bessede, C Bellera, JY Scoazec, A Italiano, C Sautès Fridman, WH Fridman, F Le Loarer

Image of the month - March

03 / 20 / 2023

Image of the month - March

Check out – It’s our Image of the BLUE March!
More than a color, more than a month…
🔵 Our everyday challenge, we are committed to our missions to fight cancer 🔵
Throughout March and beyond, we at Explicyte are calling for awareness of screening for colorectal and digestive cancers.

Image of the month - February

02 / 21 / 2023

Image of the month - February

Check out – It’s our favorite image of February!
What an incredible image we are sharing of a human TLS-positive lung biopsy!
Look carefully 🔎 to find an amazing phoenix perched as if rising from its fluorescent ashes. 🧐